[ad_1] OTTAWA July 9, 2018 / CNW / – Version: Several manufacturers of the valsartan ingredient are recalled by their manufacturers. An impurity, N-nitrosodimethylamine (NDMA), has been found in valsartan used in …
Read More »Overall reminder of a medicine for the heart due to potential contamination with a carcinogen
[ad_1] The decision was made after the manufacturer of the active pharmaceutical ingredient (API) Zhejiang Hauhai notified the European Medicines Agency (EMA) that she had detected an impurity in her production of …
Read More »